10x Genomics Reports Second Quarter 2021 Financial Results
PLEASANTON, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the second quarter ended June30, 2021.
- PLEASANTON, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the second quarter ended June30, 2021.
- Gross margin was 96% for the second quarter of 2021, as compared to 77% for the corresponding prior year period.
- This includes $26.9 million of stock-based compensation for the second quarter of 2021, as compared to $13.9 million for the second quarter of 2020.
- 10x Genomics will host a conference call to discuss the second quarter 2021 financial results, business developments and outlook after market close on Wednesday, August4, 2021 at 1:30 PM Pacific Time / 4:30 PM Eastern Time.